Advances in stem cell therapy for the lower urinary tract

Area of Science:

• Urology
• Regenerative Medicine
• Stem Cell Therapy

Background:

• Lower urinary tract diseases pose significant burdens, with current treatments offering limited efficacy.
• Stem cell therapy presents a regenerative approach for long-term solutions.
• Bone marrow-derived stem cells (BMSCs) and skeletal muscle-derived stem cells (SkMSCs) have been studied, but face limitations in quantity.

Purpose of the Study:

• To evaluate the therapeutic potential of adipose tissue-derived stem cells (ADSCs) for various lower urinary tract conditions.
• To highlight ADSCs as a viable and abundant stem cell source for urological regeneration.
• To compare the efficacy of ADSCs with other stem cell types in preclinical and clinical settings.

Main Methods:

• Review of preclinical and clinical studies investigating ADSC applications in urology.
• Analysis of ADSC differentiation capabilities into bladder smooth muscle and epithelial cells.
• Assessment of ADSC efficacy in treating conditions like overactive bladder, urethral sphincter dysfunction, and erectile dysfunction.

Main Results:

• ADSCs are easily and abundantly obtained, offering advantages over BMSCs and SkMSCs.
• ADSCs demonstrate comparable or superior therapeutic potential to BMSCs in comparative studies.
• ADSCs show efficacy in regenerating bladder tissue and treating conditions such as overactive bladder, urethral sphincter dysfunction, and various forms of erectile dysfunction.

Conclusions:

• Adipose tissue-derived stem cells (ADSCs) represent a promising, readily available cell source for regenerative urology.
• ADSC therapy has demonstrated significant potential for treating a wide range of lower urinary tract disorders.
• Further research into ADSCs is warranted for their clinical implementation in urological conditions.